ZMIZ2 and lung carcinoma: The interaction between ZMIZ2 and SIRT1 results in the activation of the Wnt pathway and inhibition of the Hippo pathway, thereby promoting the biological phenotypes of lung cancer, including cell proliferation, invasion, and metastasis.